Delivery Order SPE2DB22D1106-SPE2DB24FFAM2

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,069 units of the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen. The $3,893.17 fixed-price contract was awarded on July 3, 2024 by the Defense Logistics Agency (DLA), with a completion date of July 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,306.26 for the delivery of the medication Trulicity 4.5 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with a completion date of July 5, 2024. The contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award, valued at $1,451.40, is for the delivery of Trulicity 0.75 mg/0.5 ml pens and has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 mL pens. The contract has a ceiling value of $3,047.94 and a period of performance through July 3, 2024. It was awarded as a firm-fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4.5 mg/0.5 ml pens of the medication Trulicity. The $4,209.06 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 17, 2024. The contract has an ultimate completion date of June 18, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of the medication Trulicity 1.5 mg/0.5 ml pen in 0.5 ml quantities. The contract, valued at $6,519.80, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) and has a completion date of July 2, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,354.20 and a completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen 0.5 ml. The contract, valued at $3,223.60, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award is for the delivery of Trulicity 4.5 mg/0.5 ml pen 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,451.40 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 15, 2024, with a completion date of August 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Trulicity 3 mg/0.5 ml pen to the U.S. government. The award, valued at $5,805.60, was made by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFAM2
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government, for the delivery of Trulicity 4.5 mg/0.5 ml pen 0.5 ml. The contract, valued at $4,354.20, was awarded by the Defense Logistics Agency (DLA) on July 5, 2024 with a completion date of July 8, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/4/24, 9:02 AM